Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Margolis

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
AIDS Research and Human Retroviruses|February 15, 2011
Eradication therapies for HIV Infection: time to begin againDavid M Margolis
Current HIV/AIDS Reports|April 29, 2010
Mechanisms of HIV latency: an emerging picture of complexityDavid M Margolis
Journal of Neurovirology|July 26, 2014
Translational challenges in targeting latent HIV infection and the CNS reservoir problemCarolina Garrido, David M Margolis
Nature Chemistry|August 24, 2012
Medicinal chemistry: Forcing an enemy into the openChristian Melander, David M Margolis
Molecular and Cellular Biology|April 10, 2002
Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator TatGuocheng He, David M Margolis
Annual Review of Pharmacology and Toxicology|January 8, 2011
Curing HIV: Pharmacologic approaches to target HIV-1 latencyShailesh K Choudhary, David M Margolis
The Journal of Infectious Diseases|May 12, 2007
Eliminating persistent HIV infection: getting to the end of the rainbowDavid M Margolis, Nancie M Archin
Advances in Experimental Medicine and Biology|September 10, 2018
Correction to: HIV Persistence on Antiretroviral Therapy and Barriers to a CureJulia Marsh Sung, David M Margolis
Trends in Pharmacological Sciences|March 9, 2010
Therapy for persistent HIVKara S Keedy, David M Margolis
The Journal of Infectious Diseases|September 25, 2019
Reply to Cooper et alDaniel J Skiest, David M Margolis
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
AIDS Research and Human Retroviruses|February 15, 2011
Eradication therapies for HIV Infection: time to begin againDavid M Margolis
Current HIV/AIDS Reports|April 29, 2010
Mechanisms of HIV latency: an emerging picture of complexityDavid M Margolis
Journal of Neurovirology|July 26, 2014
Translational challenges in targeting latent HIV infection and the CNS reservoir problemCarolina Garrido, David M Margolis
Nature Chemistry|August 24, 2012
Medicinal chemistry: Forcing an enemy into the openChristian Melander, David M Margolis
Molecular and Cellular Biology|April 10, 2002
Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator TatGuocheng He, David M Margolis
Annual Review of Pharmacology and Toxicology|January 8, 2011
Curing HIV: Pharmacologic approaches to target HIV-1 latencyShailesh K Choudhary, David M Margolis
The Journal of Infectious Diseases|May 12, 2007
Eliminating persistent HIV infection: getting to the end of the rainbowDavid M Margolis, Nancie M Archin
Advances in Experimental Medicine and Biology|September 10, 2018
Correction to: HIV Persistence on Antiretroviral Therapy and Barriers to a CureJulia Marsh Sung, David M Margolis
Trends in Pharmacological Sciences|March 9, 2010
Therapy for persistent HIVKara S Keedy, David M Margolis
The Journal of Infectious Diseases|September 25, 2019
Reply to Cooper et alDaniel J Skiest, David M Margolis
Pageof 22